Announcements

Leonard Todd Kahn, an officer of Tapestry, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 30,000 shares of Tapestry common stock through Goldman Sachs & Co. LLC on the New York Stock Exchange.

Catherine Eva Spear, Chief Executive Officer and 10% Owner of FIGS, Inc., filed a Form 4 on November 9, 2026, disclosing the exercise of two stock option grants totaling 8,595,000 shares of Class A Common Stock, the withholding of shares to cover exercise prices …

AerCap Holdings N.V. Chief Financial Officer Peter Juhas filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 20,000 ordinary shares through Charles Schwab and Co. Inc. on or around November 10, 2026.

Heron Therapeutics, Inc. filed a DEFA14A with the SEC on November 9, 2026, disclosing preliminary communications related to a proposed transaction in which the company will sell substantially all of its assets to CorMedix Inc. under an Asset Purchase Agreement dated November 8, 2026.

Director Tenee R. Casaccio of Arrow Financial Corp filed a Form 4 on November 9, 2026, disclosing two transactions in common stock on November 5, 2026, involving the exercise of director stock options and a related share withholding.

Director Dayton Judd filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 17,888 shares of Lifevantage Corp common stock on November 5, 2026, under the company's outside director compensation program.

Director Raymond B. Greer filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 17,888 shares of Lifevantage Corp common stock on November 5, 2026, under the company's outside director compensation program.